These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24166227)

  • 1. Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.
    Ryan PB; Schuemie MJ; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S95-106. PubMed ID: 24166227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system.
    Ryan PB; Schuemie MJ; Gruber S; Zorych I; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S59-72. PubMed ID: 24166224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system.
    Norén GN; Bergvall T; Ryan PB; Juhlin K; Schuemie MJ; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S107-21. PubMed ID: 24166228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the empirical performance of methods for a risk identification system.
    Ryan PB; Stang PE; Overhage JM; Suchard MA; Hartzema AG; DuMouchel W; Reich CG; Schuemie MJ; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S143-58. PubMed ID: 24166231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system.
    Suchard MA; Zorych I; Simpson SE; Schuemie MJ; Ryan PB; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S83-93. PubMed ID: 24166226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating performance of risk identification methods through a large-scale simulation of observational data.
    Ryan PB; Schuemie MJ
    Drug Saf; 2013 Oct; 36 Suppl 1():S171-80. PubMed ID: 24166233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical performance of the case-control method: lessons for developing a risk identification and analysis system.
    Madigan D; Schuemie MJ; Ryan PB
    Drug Saf; 2013 Oct; 36 Suppl 1():S73-82. PubMed ID: 24166225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis system.
    Schuemie MJ; Madigan D; Ryan PB
    Drug Saf; 2013 Oct; 36 Suppl 1():S133-42. PubMed ID: 24166230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.
    Schuemie MJ; Gini R; Coloma PM; Straatman H; Herings RM; Pedersen L; Innocenti F; Mazzaglia G; Picelli G; van der Lei J; Sturkenboom MC
    Drug Saf; 2013 Oct; 36 Suppl 1():S159-69. PubMed ID: 24166232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of disproportionality safety signaling applied to healthcare databases.
    DuMouchel W; Ryan PB; Schuemie MJ; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S123-32. PubMed ID: 24166229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis system.
    Reich CG; Ryan PB; Suchard MA
    Drug Saf; 2013 Oct; 36 Suppl 1():S195-204. PubMed ID: 24166235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.
    Schuemie MJ; Trifirò G; Coloma PM; Ryan PB; Madigan D
    Stat Methods Med Res; 2016 Dec; 25(6):2577-2592. PubMed ID: 24685766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative outcome definitions and their effect on the performance of methods for observational outcome studies.
    Reich CG; Ryan PB; Schuemie MJ
    Drug Saf; 2013 Oct; 36 Suppl 1():S181-93. PubMed ID: 24166234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desideratum for evidence based epidemiology.
    Overhage JM; Ryan PB; Schuemie MJ; Stang PE
    Drug Saf; 2013 Oct; 36 Suppl 1():S5-14. PubMed ID: 24166219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions.
    Backenroth D; Chase H; Friedman C; Wei Y
    PLoS One; 2016; 11(10):e0164304. PubMed ID: 27716785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining a reference set to support methodological research in drug safety.
    Ryan PB; Schuemie MJ; Welebob E; Duke J; Valentine S; Hartzema AG
    Drug Saf; 2013 Oct; 36 Suppl 1():S33-47. PubMed ID: 24166222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.
    Takeuchi Y; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2018 Jan; 18(1):4. PubMed ID: 29310575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Case-Crossover (CCO) Study Design for Adverse Drug Event Detection.
    Burningham Z; He T; Teng CC; Zhou X; Nebeker J; Sauer BC
    Drug Saf; 2017 Sep; 40(9):789-798. PubMed ID: 28474287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS).
    Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
    Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):890-903. PubMed ID: 32524701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.